Equity Overview
Price & Market Data
Price: $9.79
Daily Change: -$0.10 / 1.02%
Daily Range: $9.63 - $10.11
Market Cap: $744,139,712
Daily Volume: 531,553
Performance Metrics
1 Week: 7.54%
1 Month: 26.62%
3 Months: 48.33%
6 Months: 4.66%
1 Year: 30.86%
YTD: 40.45%
Company Details
Employees: 74
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM120, which is in phase 3 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York.